January's Composite PMI at 58.4 reflects a healthy yet cooling expansion in the Indian economy. While manufacturing remains robust, a slight deceleration in new business intakes compared to December's peak has pulled the headline index down from 59.5.
Team Sahi
Market snapshot: India's private sector activity started 2026 on a strong footing, though at a slightly slower pace compared to the end of 2025. The HSBC India Composite PMI registered 58.4 in January, a moderate decline from the 59.5 recorded in December. Despite the sequential dip, the reading remains significantly above the 50.0 neutral mark, indicating one of the strongest growth rates globally.
Summary: January's Composite PMI at 58.4 reflects a healthy yet cooling expansion in the Indian economy. While manufacturing remains robust, a slight deceleration in new business intakes compared to December's peak has pulled the headline index down from 59.5.
The moderation to 58.4 is not a cause for alarm; rather, it indicates a normalization of growth following an exceptionally high December. With the Union Budget 2026-27 recently allocating ₹12.2 lakh crore to capital expenditure, we expect infrastructure-linked manufacturing to provide a floor for PMI figures in the coming months. For investors, this stability supports the RBI’s current neutral-to-hawkish stance on interest rates, as demand remains high enough to keep core inflation concerns alive.
While the momentum has eased from the 59.5 high, India remains the fastest-growing major economy. The PMI's resilience at 58.4 provides a solid fundamental backdrop for Indian equities in Q4 FY26.
High Performance Trading with SAHI.
Related
Recent
Fed's 2026 Outlook: Economic Resilience Meets Persistent Inflationary Pressures
Geopolitical Brinkmanship: Trump-Iran Tensions and the Indian Market Outlook
Zydus Lifesciences Disrupts Respiratory Care with India’s First Drug-Free Device 'Pepair' at ₹990
Infosys Pivots to 'AI-First' Era: New Framework Targets $300 Billion Market Opportunity
Zydus Lifesciences Disrupts Respiratory Care with India’s First Affordable Drug-Free Device ‘PepairTM’ at ₹990